Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.01M
2: EX-10.AA Material Contract HTML 51K
3: EX-10.KK Material Contract HTML 294K
4: EX-10.LL Material Contract HTML 43K
5: EX-10.MM Material Contract HTML 66K
6: EX-10.W Material Contract HTML 74K
7: EX-10.X Material Contract HTML 75K
8: EX-10.Y Material Contract HTML 73K
10: EX-21 Subsidiaries List HTML 41K
11: EX-23 Consent of Experts or Counsel HTML 44K
12: EX-24 Power of Attorney HTML 101K
9: EX-12 Statement re: Computation of Ratios HTML 53K
13: EX-31.A Certification -- §302 - SOA'02 HTML 48K
14: EX-31.B Certification -- §302 - SOA'02 HTML 48K
15: EX-32.A Certification -- §906 - SOA'02 HTML 43K
16: EX-32.B Certification -- §906 - SOA'02 HTML 43K
23: R1 Document and Entity Information HTML 69K
24: R2 Consolidated Statements of Operations HTML 114K
25: R3 Consolidated Statements of Comprehensive Income HTML 58K
26: R4 Consolidated Statements of Comprehensive Income HTML 47K
(Parenthetical)
27: R5 Consolidated Statements of Financial Position HTML 135K
28: R6 Consolidated Statements of Financial Position HTML 65K
(Parenthetical)
29: R7 Consolidated Statements of Cash Flows HTML 166K
30: R8 Consolidated Statements of Cash Flows HTML 45K
(Parenthetical)
31: R9 Consolidated Statements of Shareholders' HTML 88K
Investment
32: R10 Consolidated Statements of Shareholders' HTML 46K
Investment (Parenthetical)
33: R11 Summary of Accounting Policies HTML 51K
34: R12 Revenues HTML 46K
35: R13 Cost of Sales and Selling, General and HTML 49K
Administrative Expenses
36: R14 Consideration Received from Vendors HTML 45K
37: R15 Advertising Costs HTML 52K
38: R16 Pharmacies and Clinics Transactions (Notes) HTML 122K
39: R17 Canada Exit HTML 122K
40: R18 Restructuring Initiatives HTML 63K
41: R19 Credit Card Receivables Transaction HTML 45K
42: R20 Fair Value Measurements HTML 87K
43: R21 Cash Equivalents HTML 47K
44: R22 Inventory HTML 47K
45: R23 Other Current Assets HTML 55K
46: R24 Property and Equipment HTML 60K
47: R25 Other Noncurrent Assets HTML 54K
48: R26 Goodwill and Intangible Assets HTML 80K
49: R27 Accounts Payable HTML 44K
50: R28 Accrued and Other Current Liabilities HTML 60K
51: R29 Commitments and Contingencies HTML 71K
52: R30 Notes Payable and Long-Term Debt HTML 81K
53: R31 Derivative Financial Instruments HTML 92K
54: R32 Leases HTML 85K
55: R33 Income Taxes HTML 115K
56: R34 Other Noncurrent Liabilities HTML 56K
57: R35 Share Repurchase HTML 55K
58: R36 Share-Based Compensation HTML 113K
59: R37 Defined Contribution Plans HTML 71K
60: R38 Pension and Postretirement Health Care Plans HTML 231K
61: R39 Accumulated Other Comprehensive Income HTML 65K
62: R40 Segment Reporting HTML 94K
63: R41 Quarterly Results (Unaudited) HTML 249K
64: R42 Summary of Accounting Policies (Policies) HTML 157K
65: R43 Advertising Costs (Tables) HTML 52K
66: R44 Pharmacies and Clinics Transactions (Tables) HTML 83K
67: R45 Canada Exit (Tables) HTML 101K
68: R46 Restructuring Initiatives (Tables) HTML 65K
69: R47 Fair Value Measurements (Tables) HTML 85K
70: R48 Other Current Assets (Tables) HTML 55K
71: R49 Property and Equipment (Tables) HTML 59K
72: R50 Other Noncurrent Assets (Tables) HTML 54K
73: R51 Goodwill and Intangible Assets (Tables) HTML 74K
74: R52 Accrued and Other Current Liabilities (Tables) HTML 60K
75: R53 Commitments and Contingencies (Tables) HTML 60K
76: R54 Notes Payable and Long-Term Debt (Tables) HTML 83K
77: R55 Derivative Financial Instruments (Tables) HTML 87K
78: R56 Leases (Tables) HTML 80K
79: R57 Income Taxes (Tables) HTML 111K
80: R58 Other Noncurrent Liabilities (Tables) HTML 55K
81: R59 Share Repurchase (Tables) HTML 51K
82: R60 Share-Based Compensation (Tables) HTML 113K
83: R61 Defined Contribution Plans (Tables) HTML 69K
84: R62 Pension and Postretirement Health Care Plans HTML 242K
(Tables)
85: R63 Accumulated Other Comprehensive Income (Tables) HTML 62K
86: R64 Segment Reporting (Tables) HTML 89K
87: R65 Quarterly Results (Unaudited) (Tables) HTML 250K
88: R66 Summary of Accounting Policies (Details) HTML 46K
89: R67 Revenues (Details) HTML 51K
90: R68 Advertising Costs (Details) HTML 48K
91: R69 Pharmacies and Clinics Transactions - Narrative HTML 67K
(Details)
92: R70 Pharmacies and Clinics Transactions - Schedule of HTML 69K
Gain on Pharmacies and Clinics Transaction
(Details)
93: R71 Pharmacies and Clinics Transactions - Schedule of HTML 59K
Pharmacy and Clinic Inventory and Other Assets
(Details)
94: R72 Canada Exit - Narrative (Details) HTML 69K
95: R73 Canada Exit - Schedule of Income/(Loss) on HTML 79K
Discontinued Operations (Details)
96: R74 Canada Exit - Schedule of Pretax Exit Costs HTML 53K
(Details)
97: R75 Canada Exit - Schedule of Assets and Liabilities HTML 60K
of Discontinued Operations (Details)
98: R76 Restructuring Initiatives - Schedule of HTML 57K
Restructuring Costs (Details)
99: R77 Restructuring Initiatives - Schedule of HTML 59K
Restructuring-Related Liabilities (Details)
100: R78 Credit Card Receivables Transaction (Details) HTML 53K
101: R79 Fair Value Measurements - Schedule of Fair Value HTML 76K
Measurements - Recurring Basis (Details)
102: R80 Fair Value Measurements - Schedule of Significant HTML 48K
Financial Instruments not Measured at Fair Value
(Details)
103: R81 Cash Equivalents (Details) HTML 49K
104: R82 Inventory (Details) HTML 43K
105: R83 Other Current Assets (Details) HTML 58K
106: R84 Property and Equipment (Details) HTML 66K
107: R85 Other Noncurrent Assets (Details) HTML 55K
108: R86 Goodwill and Intangible Assets - Narrative HTML 83K
(Details)
109: R87 Goodwill and Intangible Assets - Schedule of HTML 54K
Intangible Assets (Details)
110: R88 Goodwill and Intangible Assets - Schedule of HTML 53K
Estimated Amortization Expense (Details)
111: R89 Accounts Payable (Details) HTML 45K
112: R90 Accrued and Other Current Liabilities (Details) HTML 69K
113: R91 Commitments and Contingencies - Narrative HTML 74K
(Details)
114: R92 Commitments and Contingencies - Schedule of HTML 57K
Expenses Incurred and Amounts Accrued (Details)
115: R93 Notes Payable and Long-Term Debt - Narrative HTML 73K
(Details)
116: R94 Notes Payable and Long-Term Debt - Schedule of HTML 71K
Carrying Value and Maturities of Debt Portfolio
(Details)
117: R95 Notes Payable and Long-Term Debt - Schedule of HTML 55K
Required Principal Payments (Details)
118: R96 Notes Payable and Long-Term Debt - Schedule of HTML 52K
Commercial Paper (Details)
119: R97 Derivative Financial Instruments - Narrative HTML 63K
(Details)
120: R98 Derivative Financial Instruments - Schedule of HTML 63K
Outstanding Interest Rate Swap Summary (Details)
121: R99 Derivative Financial Instruments - Schedule of HTML 63K
Classification and Fair Value (Details)
122: R100 Derivative Financial Instruments - Schedule of HTML 46K
Derivative Contracts - Effect on Results of
Operations (Details)
123: R101 Leases - Narrative (Details) HTML 68K
124: R102 Leases - Schedule of Rent Expense (Details) HTML 48K
125: R103 Leases - Schedule of Future Minimum Lease Payments HTML 111K
(Details)
126: R104 Income Taxes - Narrative (Details) HTML 83K
127: R105 Income Taxes - Schedule of Tax Rate Reconciliation HTML 61K
- Continuing Operations (Details)
128: R106 Income Taxes - Schedule of Provision for Income HTML 78K
Taxes (Details)
129: R107 Income Taxes - Schedule of Net Deferred Tax HTML 74K
Asset/(Liability) (Details)
130: R108 Income Taxes - Schedule of Reconciliation of HTML 54K
Liability for Unrecognized Tax Benefits (Details)
131: R109 Other Noncurrent Liabilities (Details) HTML 59K
132: R110 Share Repurchase - Narrative (Details) HTML 67K
133: R111 Share Repurchase - Schedule of Share Repurchases HTML 48K
(Details)
134: R112 Share-Based Compensation - Narrative (Details) HTML 96K
135: R113 Share-Based Compensation - Schedule of Restricted HTML 75K
Stock Activity and Performance Share Unit Activity
(Details)
136: R114 Share-Based Compensation - Schedule of Stock HTML 76K
Option Activity (Details)
137: R115 Share-Based Compensation - Schedule of Stock HTML 49K
Option Exercises (Details)
138: R116 Defined Contribution Plans (Details) HTML 89K
139: R117 Pension and Postretirement Health Care Plans - HTML 92K
Narrative (Details)
140: R118 Pension and Postretirement Health Care Plans - HTML 69K
Schedule of Change in Projected Benefit Obligation
(Details)
141: R119 Pension and Postretirement Health Care Plans - HTML 71K
Schedule of Change in Plan Assets (Details)
142: R120 Pension and Postretirement Health Care Plans - HTML 60K
Schedule of Recognition of Funded/(Underfunded)
Status (Details)
143: R121 Pension and Postretirement Health Care Plans - HTML 52K
Schedule of Amounts in Accumulated Other
Comprehensive Income (Details)
144: R122 Pension and Postretirement Health Care Plans - HTML 72K
Schedule of Change in Accumulated Other
Comprehensive Income (Details)
145: R123 Pension and Postretirement Health Care Plans - HTML 56K
Schedule of Expected Amortization of Amounts in
Accumulated Other Comprehensive Income (Details)
146: R124 Pension and Postretirement Health Care Plans - HTML 63K
Schedule of Net Pension Benefit Expense (Details)
147: R125 Pension and Postretirement Health Care Plans - HTML 53K
Schedule of Defined Benefit Pension Plan
Information (Details)
148: R126 Pension and Postretirement Health Care Plans - HTML 47K
Schedule of Benefit Obligation Weighted Average
Assumptions (Details)
149: R127 Pension and Postretirement Health Care Plans - HTML 51K
Schedule of Net Periodic Benefit Expense Weighted
Average Assumptions (Details)
150: R128 Pension and Postretirement Health Care Plans - HTML 60K
Schedule of Asset Category (Details)
151: R129 Pension and Postretirement Health Care Plans - HTML 68K
Schedule of Fair Value Measurements (Details)
152: R130 Pension and Postretirement Health Care Plans - HTML 56K
Schedule of Estimated Future Benefit Payments
(Details)
153: R131 Accumulated Other Comprehensive Income (Details) HTML 79K
154: R132 Segment Reporting - Schedule of Business Segment HTML 78K
Results (Details)
155: R133 Segment Reporting - Narrative (Details) HTML 51K
156: R134 Segment Reporting - Schedule of Total Assets by HTML 50K
Segments (Details)
157: R135 Quarterly Results (Unaudited) - Schedule of HTML 118K
Quarterly Results (Details)
158: R136 Quarterly Results (Unaudited) - Summary of Sales HTML 63K
by Product Category (Details)
160: XML IDEA XML File -- Filing Summary XML 290K
159: EXCEL IDEA Workbook of Financial Reports XLSX 150K
17: EX-101.INS XBRL Instance -- tgt-20160130 XML 4.14M
19: EX-101.CAL XBRL Calculations -- tgt-20160130_cal XML 425K
20: EX-101.DEF XBRL Definitions -- tgt-20160130_def XML 1.01M
21: EX-101.LAB XBRL Labels -- tgt-20160130_lab XML 2.99M
22: EX-101.PRE XBRL Presentations -- tgt-20160130_pre XML 1.70M
18: EX-101.SCH XBRL Schema -- tgt-20160130 XSD 348K
161: ZIP XBRL Zipped Folder -- 0000027419-16-000043-xbrl Zip 395K
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Target Corporation, a Minnesota corporation (“the Company”), for the year ended January 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (“the Report”), the undersigned officer of the
Company certifies pursuant to 18 U.S.C. Section 1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
